Madison Avenue Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-387,221
| Closed | -$5.72M | – | 24 |
|
|
2024
Q1 | $5.72M | Sell |
387,221
-165,864
| -30% | -$2.45M | 0.92% | 14 |
|
|
2023
Q4 | $7.42M | Hold |
553,085
| – | – | 1.05% | 14 |
|
|
2023
Q3 | $6.82M | Hold |
553,085
| – | – | 0.97% | 10 |
|
|
2023
Q2 | $6.8M | Hold |
553,085
| – | – | 1.48% | 11 |
|
|
2023
Q1 | $6.8M | Buy |
+553,085
| New | +$6.8M | 1.46% | 14 |
|